3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
3
Urogenital Neoplasms
1
Prostatic Neoplasms, Castration-Resistant
1
Prostatic Diseases
1
Neoplasms by Site
1
Neoplasms
1
Genital Neoplasms, Male
1
Genital Diseases, Male
1
Disease
1
Interventions
Magnetic Resonance Imaging
2
Cryosurgery
2
Blood Specimen Collection
2
imetelstat
1
Waiting Lists
1
Transcutaneous Electric Nerve Stimulation
1
Surveys and Questionnaires
1
Specimen Handling
1
S-Adenosylmethionine
1
Prostatectomy
1
Pluvicto
1
Observation
1
Nivolumab
1
Music Therapy
1
Mammography
1
High-Intensity Interval Training
1
Hematologic Tests
1
Fluorodeoxyglucose F18
1
Exercise
1
Equipment and Supplies
1
Educational Status
1
Diagnostic Techniques and Procedures
1
Diagnosis, Computer-Assisted
1
Bupivacaine
1
Artificial Intelligence
1
Arginine
1
Acupressure
1
2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid
1
(225)Ac-PSMA-617
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Disease
×
(225)Ac-PSMA-617
×
90 days
×
Clear all
NCT07054346
2026-04-01
LUTACT
University of California, San Francisco
Phase 1
Recruiting
45 enrolled